Drugs that contain Lapatinib Ditosylate
1. List of Tykerb drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8821927 | NOVARTIS | Pharmaceutical composition |
Sep, 2029
(6 years from now) | |
Market Authorisation Date: 13 March, 2007
Treatment: NA
Dosage: TABLET;ORAL
How can I launch a generic of TYKERB before it's patent expiration?
More Information on Dosage
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic